Monopar Therapeutics — Director's Dealing 2021

Jan 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Monopar Therapeutics (MNPR)
CIK: 0001645469
Period of Report: 2021-01-26

Reporting Person: Brown Michael J (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-26	Stock Options	$6.81	A	4443	Acquired	2031-01-25	Common Stock (4443)	Direct
2021-01-26	Restricted Stock Units	$0	A	3005	Acquired		Common Stock (3005)	Direct

Footnotes

F1: Options vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021.

F2: RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021.